Frazier Lifesciences (FLAC) to Combine with NewAmsterdam in $326M Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Frazier Lifesciences (NASDAQ:FLAC) has entered into a definitive agreement to combine with biotech firm NewAmsterdam Pharma Holding at an enterprise value of $326 million. Netherlands-based NewAmsterdam is developing a range of drugs aimed at reducing patient cholesterol levels suffering from liver, heart and brain disorders. The combined company is expected to trade on the Nasdaq
Read More